Read our June 2021 issue

We feature a combination of landscape articles and active partnering company profiles focused upon dealmaking, CNS diseases, ophthalmic diseases and infectious diseases, including vaccines.


Advances in antibody technologies

Advances in antibody technologies

Development in antibody technologies continues to diversify, providing a rich pipeline of new and innovative therapeutics. In this collection, we present antibody-focused companies, along with their technologies and therapies.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.